Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Westinghouse said to seek over $50 billion valuation in planned IPO
- JPMorgan Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
